Did You Know That… Glen Campbell
(1936 – 2017), great country music star and the winner of four Grammy awards, died of Alzheimer’s. He is one of the most admired celebrities regarding Alzheimer’s because of the way he publicized it and coped with it. He announced in 2011 that he had been diagnosed with Alzheimer’s. He planned and completed what he called his “Goodbye Tour.” He was brave enough to show the world what it’s like to have Alzheimer’s and how one might cope with it.
Successful Coping is the Key Phrase
Alzheimer’s disease. People with Alzheimer’s can see the path on which their medical situation has put them. Time goes by and at each time point along the way you have choices to make. Good choices or poor choices. Actually, most people do make good choices and live it through, live it out. Sometimes their family and friends notice the changes first. Connect with family, with friends, as best you can at each stage. Glen Campbell did it well.
Articles related to Alzheimer's:
Alzheimer’s Is Common
Though you might well feel lonely, you are not alone in your dilemma. Alzheimer’s is the most common cause of memory loss and poor cognition severe enough to make it difficult to live through each day. Most of the time people develop Alzheimer’s randomly and no one knows why. Though not common, sometimes Alzheimer’s runs in families, so in these instances it might be inherited. The older a person is the more likely you are to get Alzheimer’s.
The incidence rate is the percentage likelihood of you getting Alzheimer’s in each year. During the year that people are age 65 there is about a 1% chance of getting Alzheimer’s. During the year that people are age 85 the percentage has increased to about 6%.
The prevalence of Alzheimer’s is the number of people who have Alzheimer’s now, or in any given year or specified time period. The prevalence of Alzheimer’s for people age 65 is about 8%. That is, for every 100 people age 65 about 8 will have Alzheimer’s. By age 80 that prevalence jumps to about 40%, that is, for every 100 people age 80 abut 40 of them will have Alzheimer’s.
So, Where’s The Cure?
Dr. Daniel Skovronsky, president of Lilly Research Labs, has been quoted as saying that the complexity of Alzheimer’s disease poses one of the most difficult medical challenges of our time.
There is far too much exaggerated media coverage of promising medications for Alzheimer’s for people to know. It is most likely that no one drug in development is going to work. It will likely be a combination of medications that will finally allow progress. The mechanisms of action that are unlikely to work as single (monotherapy) medications are anti-beta-amyloid drugs, beta-secretase enzyme drugs (BACE or beta-site amyloid precursor protein cleaving enzyme), drugs targeting the tau protein, drugs that act at the 5HT-2A (serotonin 2A) receptor, or 5HT-6 (serotonin-6) receptor blocking drugs. It is certainly possible that, once safe and effective medications in two or three of these categories are found, a panel of two or more medications combined might work in Mild Cognitive Impairment (MCI or pre-Alzheimer’s) or early Alzheimer’s. Added to this panel will likely be some drug that is a specific brain anti-inflammatory, perhaps acting on the brain’s microglia cells.
An Ounce of Prevention…
It is similarly unlikely that a successful treatment or cure will be found for late mild, or moderate, or severe Alzheimer’s. Once too many neurons are gone, once too many circuits and pathways are interrupted, there is no way with today’s science and methods to regrow the brain. Pursuing all activities that avert or delay the onset of Alzheimer’s is the key. Such activities are worth their weight in gold, worth their weight in platinum, worth every bit of energy you can put into them.
As a person with Alzheimer’s moves through time, at some point along the way those who know and love them, who care about them, step up and into helping more and more. These saintly individuals have come to be called “caregivers” in the medical care system. Outside the formalism of medical care there must be better descriptors. Angels? God’s most wonderful people? They are referred to by a this special, specific “caregiver” term because they give care to the Alzheimer’s sufferer. However, over time in a different way, they need help and support for themselves. The behavioral confusion of Alzheimer’s and the resulting care needs weigh heavily on these caregivers. If you know someone caring for a person with Alzheimer’s, lend them a hand now and then. A bit of respite. A break.
Success Will Come
Medical science will conquer Alzheimer’s. Neuroscience researchers are a clever bunch. The solutions will come. It’s a difficult puzzle to understand and solve but we will get there. When? “When?” is indeed the big question. Major pharmaceutical companies and governments have spent decades and hundreds of billions of dollars and euros pushing too far in directions for which it obviously became a dead-end path. But they and we all have learned along the way. The younger you are now the greater your chance of never having Alzheimer’s or having your Mild Cognitive Impairment treated and cured.
And Now for a Bit of Medical History…
People have always become demented and physicians have always noticed. Concepts have evolved over time. We can start with those famous ancient Greek physicians. Pythagoras (570 – 495 BCE) thought dementia was the expected decay of the body and mind in old age. Hippocrates (460 – 370 BCE) called dementia “paranoia” and thought it was just part of growing old, and his student Plato (425 – 347 BCE) pretty much agreed. The Romans evolved the thinking a bit, with Cicero (106 – 43 BCE) being the first in history to suggest that an active mental life might prevent or postpone cognitive decline. Galen (129 – 216 AD) called dementia “morosis” and listed it as a disease.
All Western medical science and research decayed and disappeared during the Medieval “Dark Ages”. (Thanks, Catholic Church.). Finally Jaso de Pratis in 1549 had a chapter on dementia in his first-ever neurology textbook, then Thomas Willis (1621 – 1675) described cognitive loss in the elderly. Philippe Pinel (1745 -1826) removed chains from those with dementia, who were housed in asylums with the mentally ill, and in the 1800s his student Esquirol included senile dementia in his first-ever modern classification of mental disease. In 1860 Morel described brain atrophy with aging.
The famous psychiatrist, Dr. Alois Alzheimer, recorded specific and unique symptoms of a dementing disorder 1906, based on Auguste Deter, one of his female patients who developed Alzheimer’s dementia in her 50s. She had memory loss, paranoia, and other cognitive losses, and at autopsy Dr. Alzheimer noted shrinkage in specific brain areas. Dr. Alzheimer published his findings in 1909 and in 1910 another famous psychiatrist, Dr. Emil Kraepelin, was the first to use the term “Alzheimer’s Disease” when he published Dr. Alzheimer’s work in a new edition of his textbook of psychiatry. By 2010 Alzheimer’s disease was the 6th leading cause of death in the U.S.
Alzheimer’s Foundation of America
National Institutes of Health, National Institute on Aging Alzheimer’s Disease
Center for Disease Control and Prevention (CDC) Alzheimer’s Disease
Mayo Clinic Alzheimer’s Disease